文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

Cancer: The nuances of therapy.

作者信息

Ellis Lee M, Reardon David A

出版信息

Nature. 2009 Mar 19;458(7236):290-2. doi: 10.1038/458290a.

DOI:10.1038/458290a

Abstract

摘要

相似文献

[1]

Cancer: The nuances of therapy.

Nature. 2009-3-19

[2]

Oncologist. 2010-8-5

[3]

VEGF inhibition and metastasis: possible implications for antiangiogenic therapy.

Cancer Biol Ther. 2009-7

[4]

Cancer. Encouraging results for second-generation antiangiogenesis drugs.

Science. 2005-5-27

[5]

How well do angiogenesis inhibitors work? Biomarkers of response prove elusive.

J Natl Cancer Inst. 2009-6-16

[6]

The horizon of antiangiogenic therapy for colorectal cancer.

Oncology (Williston Park). 2005-3

[7]

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.

Curr Med Chem. 2006

[8]

[Treatment with antiangiogenic drugs].

Nihon Rinsho. 2010-6

[9]

Targeted drugs for metastatic renal cell carcinoma.

Lancet. 2007-12-22

[10]

Targeted therapies: bevacizumab--has it reached its final resting place?

Nat Rev Clin Oncol. 2011-3-8

引用本文的文献

[1]

Inhibitory effects of icotinib combined with antiangiogenic drugs in human non-small cell lung cancer xenograft models are better than single target drugs.

Thorac Cancer. 2022-1

[2]

Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.

Drug Deliv Transl Res. 2021-12

[3]

Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research.

Cancers (Basel). 2019-11-1

[4]

Humanized mouse models of immunological diseases and precision medicine.

Mamm Genome. 2019-3-7

[5]

Consensus guidelines for the use and interpretation of angiogenesis assays.

Angiogenesis. 2018-8

[6]

Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.

PLoS One. 2017-9-22

[7]

Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.

Oncogene. 2017-11-23

[8]

Targeting angiogenesis in small cell lung cancer.

Transl Lung Cancer Res. 2016-8

[9]

Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy.

Proc Natl Acad Sci U S A. 2016-4-12

[10]

Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma.

Cancer Sci. 2015-8

本文引用的文献

[1]

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Cancer Cell. 2009-3-3

[2]

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.

Cancer Cell. 2009-3-3

[3]

Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).

J Clin Oncol. 2008-11-20

[4]

Sorafenib in advanced hepatocellular carcinoma.

N Engl J Med. 2008-7-24

[5]

VEGF-targeted therapy: mechanisms of anti-tumour activity.

Nat Rev Cancer. 2008-8

[6]

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.

Cancer Cell. 2008-3

[7]

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.

J Clin Oncol. 2007-10-20

[8]

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy.

Proc Natl Acad Sci U S A. 2007-10-23

[9]

Autocrine VEGF signaling is required for vascular homeostasis.

Cell. 2007-8-24

[10]

Sorafenib in advanced clear-cell renal-cell carcinoma.

N Engl J Med. 2007-1-11

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索